Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Natalia Sousa Freitas Queiroz"'
Autor:
Carolina Bortolozzo Graciolli FACANALI, Marcio Roberto FACANALI JUNIOR, Ulysses RIBEIRO JUNIOR, Natalia Sousa Freitas QUEIROZ, Carlos Walter SOBRADO JUNIOR, Adriana Vaz SAFATLE-RIBEIRO
Publikováno v:
Arquivos de Gastroenterologia, Vol 59, Iss 1, Pp 117-122 (2022)
ABSTRACT Background Behçet’s disease is a rare immune-mediated disorder that can affect the gastrointestinal tract. The prevalence and extension of small bowel involvement is largely unknown. Objective The aim of this study was to describe the sma
Externí odkaz:
https://doaj.org/article/103abe2999f84dd396dbf23429f58323
Autor:
Cintia Mayumi Sakurai Kimura, Arceu Scanavini Neto, Natalia Sousa Freitas Queiroz, Natally Horvat, Mariane Gouvea Monteiro Camargo, Marcelo Rodrigues Borba, Carlos Walter Sobrado, Ivan Cecconello, Sergio Carlos Nahas
Publikováno v:
Inflammatory Intestinal Diseases, Pp 1-7 (2020)
Introduction: Abdominal surgery in patients with Crohn’s disease (CD) is challenging, especially in the biologic era. The aim of this study was to evaluate factors associated with increased risk for postoperative complications in CD. Methods: A ret
Externí odkaz:
https://doaj.org/article/18bc172edf9d4ed0bedad662d9375fb4
Autor:
Karoline Soares Garcia, Bruna Damásio Moutinho, Matheus Freitas Cardoso de Azevedo, Natalia Sousa Freitas Queiroz, Luciane Reis Milani, Lucas Navarro Sanches, Luisa Leite Barros, Jane Oba, Alexandre de Sousa Carlos, Aderson Omar Mourão Cintra Damião, Aytan Miranda Sipahi
Publikováno v:
Inflammatory Intestinal Diseases, Vol 5, Iss 2, Pp 93-98 (2020)
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has increased concern regarding SARS-CoV-2 infection in inflammatory bowel disease (IBD) patients, especially those on immunosuppressive therapies or with active disease. There are limite
Externí odkaz:
https://doaj.org/article/91d328e52bec4d948faba2f9668fb7d9
Autor:
Camilla de Almeida Martins, Ana Elisa Rabe Caon, Carolina Bortolozzo Graciolli Facanali, Carlos Walter Sobrado, Sergio Carlos Nahas, Rosa Maria Rodrigues Pereira, Reuma Margalit-Yehuda, Uri Kopylov, Natalia Sousa Freitas Queiroz
Publikováno v:
Gastroenterology Research and Practice, Vol 2021 (2021)
Background. Takayasu’s arteritis (TA) and inflammatory bowel disease (IBD) are chronic inflammatory granulomatous disorders that have rarely been concomitantly reported in case reports and small case series. Objective. We report a series of seven c
Externí odkaz:
https://doaj.org/article/30a6a60d7249444ba88b2cedb32d5ed5
Autor:
Ramir Luan Perin, Daniela Oliveira Magro, Adriana Ribas Andrade, Marjorie Argollo, Nayara Salgado Carvalho, Adérson Omar Moura Cintra Damião, Adriana Zanoni Dotti, Sandro da Costa Ferreira, Cristina Flores, Juliano Coelho Ludvig, Rodrigo Bremer Nones, Natalia Sousa Freitas Queiroz, Rogério Serafim Parra, Flavio Steinwurz, Fabio Vieira Teixeira, Paulo Gustavo Kotze
Publikováno v:
Crohn's & Colitis 360. 5
Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease which affects the colorectal mucosa with a relapsing–remitting pattern. The therapeutic options currently available for the medical management of UC include many options. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2486f0caa6300d2157c237bd6bb168e
https://doi.org/10.1093/crocol/otac050
https://doi.org/10.1093/crocol/otac050
Autor:
Lucas Rodrigues Boarini, Carlos Walter Sobrado, Giana Rabello Mota, Luisa Lina Villa, Idblan Carvalho de Albuquerque, Natalia Sousa Freitas Queiroz, Carolina Bortolozzo Graciolli Facanali, Sidney Roberto Nadal, Ivan Cecconello
Publikováno v:
Clinics, Volume: 78, Article number: 100219, Published: 10 JUL 2023
Background & Aims Perianal fistulizing Crohn's disease is the main risk factor for anal cancer in patients with inflammatory bowel disease. Whether this occurs due to a higher frequency of human papillomavirus remains unclear. The authors aimed to ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b5775e9ed3e9bab7738d6900082825
https://doi.org/10.1016/j.clinsp.2023.100219
https://doi.org/10.1016/j.clinsp.2023.100219
Autor:
Carolina Bortolozzo Graciolli FACANALI, Marcio Roberto FACANALI JUNIOR, Ulysses RIBEIRO JUNIOR, Natalia Sousa Freitas QUEIROZ, Carlos Walter SOBRADO JUNIOR, Adriana Vaz SAFATLE-RIBEIRO
Publikováno v:
Arquivos de Gastroenterologia v.59 n.1 2022
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE
Arquivos de Gastroenterologia, Volume: 59, Issue: 1, Pages: 117-122, Published: 15 APR 2022
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE
Arquivos de Gastroenterologia, Volume: 59, Issue: 1, Pages: 117-122, Published: 15 APR 2022
Background Behçet’s disease is a rare immune-mediated disorder that can affect the gastrointestinal tract. The prevalence and extension of small bowel involvement is largely unknown. Objective The aim of this study was to describe the small bowel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::238abb850cccc4ff00b327d89c026f8d
https://pubmed.ncbi.nlm.nih.gov/35442321
https://pubmed.ncbi.nlm.nih.gov/35442321
Autor:
Roberta Krause Romero, Daniela Oliveira Magro, Natalia Sousa Freitas Queiroz, Aderson Omar Mourão Cintra Damião, Fabio Vieira Teixeira, Rodrigo Bremer Nones, Ligia Yukie Sassaki, Rogerio Saad-Hossne, Paulo Gustavo Kotze
Publikováno v:
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Made available in DSpace on 2022-05-01T10:18:58Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01 Background: In the last decade, new therapies with different mechanisms of action have been approved for the treatment of moderate to severe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f3e6402f5904813b0afe0dc436e5f0b
Autor:
Camilla de Almeida Martins, Matheus Freitas Cardoso de Azevedo, Alexandre Sousa Carlos, Aderson Omar Mourão Cintra Damião, Carlos Walter Sobrado Junior, Sergio Carlos Nahas, Natália Sousa Freitas Queiroz
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: Biological therapies have revolutionized the treatment of patients with inflammatory bowel disease (IBD). Infliximab (IFX) has been shown to be effective in inducing and maintaining remission in patients with Crohn’s disease and ulcerat
Externí odkaz:
https://doaj.org/article/5cfd1ca8e5474ee9832b98f121b984d0
Autor:
Matheus Freitas Cardoso de Azevedo, Luísa Leite Barros, Filipe Fernandes Justus, Jane Oba, Karoline Soares Garcia, Camilla de Almeida Martins, Alexandre de Sousa Carlos, André Zonetti Arruda Leite, Aytan Miranda Sipahi, Natália Sousa Freitas Queiroz, Adérson Omar Mourão Cintra Damião
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background/Aims: Anti-tumor necrosis factor (anti-TNF) drugs have been the mainstay therapy for moderate to severe inflammatory bowel disease (IBD) over the past 25 years. Nevertheless, these drugs are associated with serious opportunistic infections
Externí odkaz:
https://doaj.org/article/e170d93ec28645a19b9a9c3b4109c888